Diffuse alopecia areata induced by brentuximab vedotin therapy for advanced stage mycosis fungoides.

Authors	Elena Canal-Garcia, Francesc Alamon-Reig, Andrea Combalia
Journal	Dermatologic therapy (Dermatol Ther) Vol. 35 Issue 5 Pg. e15427 (05 2022) ISSN: 1529-8019 [Electronic] United States
PMID	35262989 (Publication Type: Letter)
Chemical References	Brentuximab Vedotin
Topics	Alopecia Areata (chemically induced, diagnosis, drug therapy) Brentuximab Vedotin (adverse effects) Humans Mycosis Fungoides (diagnosis, drug therapy) Skin Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!